ID
35149
Beschrijving
Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings; ODM derived from: https://clinicaltrials.gov/show/NCT02440854
Link
https://clinicaltrials.gov/show/NCT02440854
Trefwoorden
Versies (1)
- 19-02-19 19-02-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
19 februari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Carcinoma, Non-Small-Cell Lung NCT02440854
Eligibility Carcinoma, Non-Small-Cell Lung NCT02440854
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Afatinib | Therapeutic procedure Initiation Before Enrollment
Datatype
boolean
Alias
- UMLS CUI [1]
- C2987648
- UMLS CUI [2,1]
- C0087111
- UMLS CUI [2,2]
- C1704686
- UMLS CUI [2,3]
- C0332152
- UMLS CUI [2,4]
- C1516879
Beschrijving
Medical contraindication Investigational New Drugs
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0013230
Beschrijving
Investigational New Drugs
Datatype
boolean
Alias
- UMLS CUI [1]
- C0013230
Similar models
Eligibility Carcinoma, Non-Small-Cell Lung NCT02440854
- StudyEvent: Eligibility
C0029921 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C3258246 (UMLS CUI [1,4])
C0278987 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C2984891 (UMLS CUI [3])
C0332197 (UMLS CUI [1,2])
C2114399 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2])
C0087111 (UMLS CUI [2,1])
C1704686 (UMLS CUI [2,2])
C0332152 (UMLS CUI [2,3])
C1516879 (UMLS CUI [2,4])
C0013230 (UMLS CUI [1,2])